FIA
AZN icon

FNY Investment Advisers’s AstraZeneca AZN Stock Holding History

FNY Investment Advisers’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Sell
200
-7,250
-97% -$1.36M 1.01% 16
2026
Q1 		$4.37M Buy
7,450
+7,350
+7,350% +$1.42M 1.91% 7
2025
Q4 		$2.76M Hold
100
– – 0.78% 24
2025
Q3 		$2.24M Hold
100
– – 0.72% 22
2025
Q2 		$2.02M Sell
100
-200
-67% -$28K 0.86% 25
2025
Q1 		$2.28M Buy
300
+200
+200% +$28.9K 1.39% 12
2024
Q4 		$2.09M Hold
100
– – 1.08% 25
2024
Q3 		$2.32M Hold
100
– – 1.12% 19
2024
Q2 		$2.47M Buy
+100
New +$15K 1.66% 12
2023
Q4 		– Sell
-12,400
Closed -$1.68M – 480
2023
Q3 		$1.68M Buy
+12,400
New +$1.69M 1% 16
2022
Q4 		– Sell
-29,017
Closed -$3.18M – 507
2022
Q3 		$3.18M Buy
+29,017
New +$3.68M 2.2% 7
2022
Q1 		– Sell
-3,000
Closed -$360K – 742
2021
Q4 		$349K Sell
3,000
-17,805
-86% -$2.1M 0.19% 123
2021
Q3 		$2.5M Buy
+20,805
New +$2.42M 1.16% 22
2021
Q2 		– Sell
-24,480
Closed -$2.43M – 776
2021
Q1 		$2.43M Sell
24,480
-56,214
-70% -$5.65M 0.91% 27
2020
Q4 		$8.07M Buy
80,694
+74,754
+1,258% +$7.92M 2.2% 8
2020
Q3 		$651K Buy
+5,940
New +$661K 0.28% 81
2020
Q2 		– Sell
-1
Closed – – 420
2020
Q1 		$0 Sell
1
-12,499
-100% -$1.18M ﹤0.01% 456
2019
Q4 		$1.25M Buy
+12,500
New +$1.18M 0.39% 41
2018
Q3 		– Sell
-2,500
Closed -$175K – 907
2018
Q2 		$175K Buy
+2,500
New +$180K 0.07% 170

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

FNY Investment Advisers's AZN Position: Q2 2026 in Review

FNY Investment Advisers reduced its AstraZeneca (AZN) stake by 97% in Q2 2026, selling an estimated $1.36M and leaving 200 shares worth $2.82M. The position accounts for 1.01% of the portfolio, ranked #16.

FNY Investment Advisers first reported a position in AZN in Q2 2018 and has held it in 19 quarters since. The position peaked at $8.07M in Q4 2020. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • FNY Investment Advisers held 200 shares of AstraZeneca worth $2.82M as of Q2 2026.
  • FNY Investment Advisers sold 7,250 AstraZeneca shares in Q2 2026, an estimated $1.36M.
  • AstraZeneca made up 1.01% of FNY Investment Advisers's portfolio in Q2 2026, its #16 holding.
  • FNY Investment Advisers first reported a position in AstraZeneca in Q2 2018 and has held it in 19 quarters since.
  • FNY Investment Advisers's AstraZeneca position peaked at $8.07M in Q4 2020.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.